Latest Breaking News On - Novartis global pharmaceuticals - Page 1 : vimarsana.com

The Bill & Melinda Gates Medical Research Institute (Gates MRI) today announced the appointment of Patrice Matchaba, MD, as Chief Executive Officer (CEO), starting June 10, 2024. He succeeds the current CEO, Emilio Emini, PhD, who recently announced his retirement, effective on June 30, 2024. Dr. Matchaba began his career as a physician in South

United statesSouth africaKwazulu natalCape townWestern capeSouth africanTrevor mundelEmilio eminiPatrice matchabaMelinda gates foundationCochrane centreNovartis global pharmaceuticalsAfrican medical research centreNovartis group head of global healthNovarti us foundationGlobal health